Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P a | HR | 95% CI | P a | |
HCC patients | ||||||
 Gender (male/female) | 1.333 | 0.747–2.377 | 0.331 |  |  |  |
 HBV infection (no/yes) | 0.863 | 0.431–1.729 | 0.678 |  |  |  |
 Alpha-fetoprotein, ng/mL (≤25/>25) | 1.023 | 1.003–1.043 | 0.027 |  |  | NA |
 Child–Pugh class (A/B) | 1.626 | 0.782–3.378 | 0.193 |  |  |  |
 Histological grage (I/II/III/other) | 1.42 | 0.901–2.237 | 0.131 |  |  |  |
 Tumor number (single/multiple) | 3.178 | 2.008–5.031 | < 0.0001 |  |  | NA |
 Tumor size, cm (≤5/>5) | 1.838 | 1.154–2.927 | 0.01 | 1.614 | 0.997–2.613 | 0.051 |
 Vascular invasion (absent/present) | 3.832 | 1.825–8.046 | < 0.0001 | 2.667 | 1.208–5.888 | 0.015 |
 TNM stage (I vs. II + III) | 3.383 | 2.164–5.289 | < 0.0001 | 2.838 | 1.765–4.564 | 0.0002 |
 \( {\text{CD2}}0 4_{IT}^{ + } \) cells (low/high) | 1.922 | 1.217–3.034 | 0.005 | 2.125 | 1.298–3.478 | 0.003 |
 \( {\text{CD169}}_{IT}^{ + } \) cells (low/high) | 0.561 | 0.358–0.878 | 0.011 | 0.436 | 0.270–0.703 | 0.001 |
GC patients | ||||||
 Gender (male/female) | 1.189 | 0.702–2.013 | 0.52 |  |  |  |
 Tumor size, cm (≤4/>4) | 1.655 | 0.951–2.881 | 0.075 |  |  |  |
 Tumor depth (pT1 + pT2 + pT3/pT4) | 1.251 | 0.744–2.105 | 0.398 |  |  |  |
 Lymph node metastasis (pN0 + pN1/pN2 + pN3) | 1.999 | 1.192–3.353 | 0.009 | 2.012 | 1.178–3.437 | 0.011 |
 TNM stage (I + II vs. III + IV) | 2.031 | 1.103–3.738 | 0.023 |  |  | NA |
 Histological grage (I/II/III/other) | 1.18 | 0.772–1.804 | 0.445 |  |  |  |
 \( {\text{CD2}}0 4_{IT}^{ + } \) cells (low/high) | 1.033 | 0.625–1.709 | 0.899 |  |  |  |
 \( {\text{CD169}}_{IT}^{ + } \) cells (low/high) | 0.569 | 0.343–0.943 | 0.029 | 0.587 | 0.354–0.974 | 0.039 |